Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 125 of 135 entries
View as:

Study of Safety and Efficacy of Antihemophilic Factor/Von Willebrand Factor Complex in Surgical Subjects With Von Willebrand Disease (vWD)

Phase: N/A Priority: Normal
NCT ID: NCT00168090 Org: User:
Start: 10/31/01 End: 05/31/06 Due: 05/31/07

Study of Biostate® in Children With Von Willebrand Disease

Phase: N/A Priority: Normal
NCT ID: NCT01213446 Org: User:
Start: 08/31/10 End: 08/31/13 Due: 08/31/14

Vascular Endothelial Growth Factor-B (VEGF-B) Blockade With the Monoclonal Antibody CSL346 in Subjects With Diabetic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT04419467 Org: User:
Start: 09/14/20 End: 10/24/22 Due: 10/24/23

Extension Study of Maintenance Treatment With Subcutaneous Immunoglobulin (IgPro20) for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Phase: N/A Priority: Normal
NCT ID: NCT02027701 Org: User:
Start: 07/30/14 End: 07/10/17 Due: 07/10/18

An Observational Cohort Study to Investigate the Risk of Thromboembolic Events in Patients Receiving Kcentra® or Plasma to Reverse Vitamin K Antagonist (VKA) Therapy in the Setting of Acute Major Bleeding

Phase: N/A Priority: Normal
NCT ID: NCT02319460 Org: User:
Start: 04/24/14 End: 06/30/20 Due: 06/30/21

Study of Biostate® in Children With Hemophilia A

Phase: N/A Priority: Normal
NCT ID: NCT01229007 Org: User:
Start: 08/31/10 End: 07/31/14 Due: 07/31/15

Study to Assess CSL787 in Non-cystic Fibrosis Bronchiectasis (NCFB)

Phase: N/A Priority: Normal
NCT ID: NCT04643587 Org: User:
Start: 12/07/20 End: 03/12/23 Due: 03/12/24

Treatment of GVHD in Hematopoietic Stem Cell Transplant (HSCT) Recipients Using AAT Plus Corticosteroids (CS) Compared With Corticosteroids Alone (BMT CTN 1705)

Phase: N/A Priority: Normal
NCT ID: NCT04167514 Org: User:
Start: 01/09/20 End: 05/12/25 Due: 05/12/26

Safety and Pharmacokinetics of IgPro20 and IgPro10 in Adults With Systemic Sclerosis (SSc)

Phase: N/A Priority: Normal
NCT ID: NCT04137224 Org: User:
Start: 09/19/19 End: 05/17/22 Due: 05/17/23

Observatory of Patients With Haemophilia B Treated by IdElvion®

Phase: N/A Priority: Normal
NCT ID: NCT05086575 Org: User:
Start: 12/03/21 End: 12/31/27 Due: 12/31/28

A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.

Phase: N/A Priority: Normal
NCT ID: NCT02108262 Org: User:
Start: 08/31/14 End: 03/31/16 Due: 03/31/17

A Study to Evaluate the Safety and Pharmacokinetics of Two Formulations of C1-esterase Inhibitor

Phase: N/A Priority: Normal
NCT ID: NCT01760343 Org: User:
Start: 01/31/13 End: 03/31/13 Due: 03/31/14

Study of a Prothrombin Complex Concentrate for Rapid Reversal of Coagulopathy Induced by Vitamin K Antagonists in Japanese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02281201 Org: User:
Start: 10/31/14 End: 03/31/16 Due: 03/31/17

A Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema

Phase: N/A Priority: Normal
NCT ID: NCT01912456 Org: User:
Start: 01/31/14 End: 10/31/15 Due: 10/31/16

A Study to Evaluate the Long-term Clinical Safety and Efficacy of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema

Phase: N/A Priority: Normal
NCT ID: NCT02316353 Org: User:
Start: 12/31/14 End: 09/21/17 Due: 09/21/18

Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT03473223 Org: User:
Start: 03/21/18 End: 11/17/23 Due: 11/17/24

Pharmacokinetics and Safety of Subcutaneous CSL324 in Healthy Japanese and White Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04570267 Org: User:
Start: 10/08/20 End: 12/09/21 Due: 12/09/22

Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01403064 Org: User:
Start: 07/31/11 End: 03/31/14 Due: 03/31/15

Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Chinese Subjects With Hemophilia B Previously Treated With FIX Therapy

Phase: N/A Priority: Normal
NCT ID: NCT06399289 Org: User:
Start: 06/28/24 End: 12/31/26 Due: 12/31/27

Two Dose Levels of Privigen in Pediatric CIDP

Phase: N/A Priority: Normal
NCT ID: NCT03684018 Org: User:
Start: 02/28/19 End: 12/20/29 Due: 12/20/30

An Open-label Safety, Efficacy and Pharmacokinetic Study of a Recombinant FVIII Compared to Recombinant Human Antihemophilic FVIII in Patients With Severe Hemophilia A

Phase: N/A Priority: Normal
NCT ID: NCT01486927 Org: User:
Start: 02/29/12 End: 12/31/14 Due: 12/31/15

A Study Investigating the Effectiveness and Safety of Garadacimab for Treating Patients With Hereditary Angioedema (HAE)

Phase: N/A Priority: Normal
NCT ID: NCT07001280 Org: User:
Start: 06/30/25 End: 08/31/30 Due: 08/31/31

A Study of Factor XIII Concentrate in Subjects With Congenital Factor XIII Deficiency

Phase: N/A Priority: Normal
NCT ID: NCT00885742 Org: User:
Start: 08/31/09 End: 04/30/11 Due: 04/30/12

A Study of CSL112 in Healthy Adults and in Adults With Moderate Renal Impairment

Phase: N/A Priority: Normal
NCT ID: NCT02427035 Org: User:
Start: 05/31/15 End: 02/29/16 Due: 02/28/17

A Study to Investigate CSL312 in Subjects With Hereditary Angioedema (HAE)

Phase: N/A Priority: Normal
NCT ID: NCT03712228 Org: User:
Start: 10/29/18 End: 10/15/21 Due: 10/15/22